Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Future Oncology (London, England)|June 21, 2016
The delineation of intraprostatic boost regions for radiotherapy using multimodality imagingAngela U Pathmanathan, Emma J Alexander, Robert A Huddart, et al.
BJU International|June 8, 2007
The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumoursRamachandran Venkitaraman, Bernadette Johnson, Robert A Huddart, et al.
BJU International|October 19, 2007
Efficacy of low-dose dexamethasone in castration-refractory prostate cancerRamachandran Venkitaraman, Karen Thomas, Robert A Huddart, et al.
Nuclear Medicine Communications|March 11, 2015
The role of 18F-FDG PET/CT in the management of testicular cancersGary J Cook, Aslam Sohaib, Robert A Huddart, et al.
Cancer|September 5, 2002
Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for managementMehdi Shahidi, Andrew R Norman, David P Dearnaley, et al.
Cancer|March 13, 2010
Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancerJennifer L Glendenning, Yolanda Barbachano, Andy R Norman, et al.
BJU International|July 13, 2006
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapyDuncan C Gilbert, Andrew R Norman, Judith Nicholl, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2020
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)Fay H Cafferty, Jeff D White, Jonathan Shamash, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Technological advances in radiotherapy for the treatment of localised prostate cancerStephen A Mangar, Robert A Huddart, Christopher C Parker, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillanceRamachandran Venkitaraman, Karen Thomas, Phillip Grace, et al.
Pageof 10